Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
6 pending office actions • 3 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Fujifilm Cellular Dynamics Inc. is currently managing 7 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct art units, which indicates that the company's patent applications cover a variety of specialized fields. The company is interacting with 7 distinct examiners, meaning that every single pending action is being reviewed by a different official.
The busiest examiner for the company is SPENCE, JENNIFER SUZANNE, who is responsible for 1 busiest examiner pending action. Because the 7 pending office actions are spread among different examiners, no single official has a dominant influence over the portfolio's current progress. This distribution requires the company to adapt its prosecution strategy to the individual styles of many different people. Furthermore, the 4 distinct art units involved mean that the company must navigate the specific procedural nuances of different administrative groups within the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 1 (17%) |
| §112 only | 1 (17%) |
| Double-patenting + other | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
| KIM, TAEYOON | 1 | 51.5% | +52.1% |
| NGUYEN, NGHI V | 1 | 53.6% | +50.8% |
| SUNG, GERALD LUTHER | 1 | 79.9% | +28.6% |
| STAVROU, CONSTANTINA E | 1 | 43.7% | +36.9% |
| NOBLE, MARCIA STEPHENS | 1 | 67.0% | +39.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18824380 | METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF | SPENCE, JENNIFER SUZANNE | — |
| 18479052 | APPARATUS AND METHODS FOR DELIVERY OF CELL COMPOSITIONS | SUNG, GERALD LUTHER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18824380 | METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF | SPENCE, JENNIFER SUZANNE | — |
| 18769320 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | KIM, TAEYOON | — |
| 18554103 | DOPAMINERGIC PRECURSOR CELLS AND METHODS OF USE | NGUYEN, NGHI V | — |
| 18479052 | APPARATUS AND METHODS FOR DELIVERY OF CELL COMPOSITIONS | SUNG, GERALD LUTHER | — |
| 17931440 | COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF | STAVROU, CONSTANTINA E | — |
| 16782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | NOBLE, MARCIA STEPHENS | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 1653 | 1 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18824380 | METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF | SPENCE, JENNIFER SUZANNE | — | §101§102§103DP | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18769320 | METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS | KIM, TAEYOON | — | §102§103§112DP | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18554103 | DOPAMINERGIC PRECURSOR CELLS AND METHODS OF USE | NGUYEN, NGHI V | 1653 | §102§112DP | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18479052 | APPARATUS AND METHODS FOR DELIVERY OF CELL COMPOSITIONS | SUNG, GERALD LUTHER | 3741 | §102§103§112 | Non-Final OA | — | Pending | Sep 30, 2023 |
| 17931440 | COMPOSITIONS OF INDUCED PLURIPOTENT STEM CELL-DERIVED CELLS AND METHODS OF USE THEREOF | STAVROU, CONSTANTINA E | 1632 | §103 | Final Rejection | — | Pending | Sep 12, 2022 |
| 16782772 | METHODS FOR DIFFERENTIATING PLURIPOTENT CELLS | NOBLE, MARCIA STEPHENS | 1632 | §112 | Non-Final OA | — | Pending | Feb 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial